Safety & Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute

Clinical Trial Description

Biohaven Pharmaceuticals, Inc. is the agent for BioShin Limited, the sponsor of the studies in China and Korea. ;

Study Design

See also
Status	Clinical Trial	Phase
Completed	`NCT04153409` - A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine	Phase 2
Completed	`NCT02279082` - DFN-02 Open Label Safety Study in Patients With Acute Migraine	Phase 3
Completed	`NCT01973205` - Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine	Phase 3
Terminated	`NCT04089761` - Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents	N/A
Completed	`NCT03631550` - The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine	N/A
Completed	`NCT01267864` - Valproate Versus Ketorolac Versus Metoclopramide	Phase 4
Completed	`NCT05371652` - A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants	Phase 3
Completed	`NCT04218162` - Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean	Phase 3
Completed	`NCT01730326` - Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack	Phase 4
Completed	`NCT04408794` - Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine	Phase 2/Phase 3
Completed	`NCT02745392` - Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine	Phase 2/Phase 3
Completed	`NCT00894556` - A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)	Phase 3
Terminated	`NCT02185703` - Chordate System S020 Acute Migraine Clinical Investigation	N/A
Terminated	`NCT01680029` - PBASE-system Acute Migraine Clinical Investigation	N/A
Completed	`NCT01358279` - Transcranial Direct Current Stimulation for Migraine Attack	N/A
Not yet recruiting	`NCT01228552` - The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine	Phase 3
Completed	`NCT02684409` - Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine	Phase 1
Completed	`NCT02439320` - Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:	Phase 3
Terminated	`NCT01112553` - Treximet Migraine Brain Imaging Research Study	N/A
Completed	`NCT01276977` - Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine	N/A

NCT number	NCT04574362
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 3
Start date	October 22, 2020
Completion date	December 16, 2021

Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms